CD8+ T-cell-mediated response to Listeria monocytogenes taken up in the liver and replicating within hepatocytes

Immunological Reviews

Volumn 174, Issue , 2000, Pages 112-122

  Gregory, Stephen H ^a   Liu, Chau Ching ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD8 ANTIGEN; CYTOKINE; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BACTERIAL GROWTH; BLOODBORNE BACTERIUM; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HEPATITIS; HOST RESISTANCE; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER CELL; LIVER CELL DAMAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD95; APOPTOSIS; BACTERIAL TOXINS; CASPASES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME ACTIVATION; FAS LIGAND PROTEIN; H-2 ANTIGENS; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; PORE FORMING CYTOTOXIC PROTEINS;

EID: 0034113664     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017405.x     Document Type: Review

References (134)

1. 1. Benacerraf B, Sebestyen M, Schlossman S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp Med 1959;110:27-48.
2. 2. Brandborg LL, Goldman IS. Bacterial and miscellaneous infections of the liver. In: Zakim D, Boyer T D, eds. Hepatology: a textbook of liver disease. Philadelphia: WB Saunders; 1990. p. 1086-1098.
3. 3. North RJ. T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis. Infect Immun 1974;10:66-71.
4. 4. Zimmerman HJ, Fang M, Utili R, Seeff LB, Hoofnagle J. Jaundice due to bacterial infection. Gastroenterology 1978;77:362-374.
5. 5. Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996;157:2514-2520.
6. 6. Gregory SH, Barczynski LK, Wing EJ. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections. J Leukoc Biol 1992;51:421-424.
7. 7. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-163.
8. + cells in acquired immunity. Infect Immun 1988;56:1920-1925.
9. 9. Baldridge JR, Barry RA, Hinrichs DJ. Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T cell subsets. Infect Immun 1990;58:654-658.
10. + T cell subset: a study with Listeria-specific T lymphocytes recovered from murine infected liver. Int Immunol 1992;4:591-598.
11. 11. Ladel CH, Flesch IEA, Arnoldi J, Kaufmann SHE. Studies with MHC-deficient knock-out mice reveal impact of both MHC I-and MHC II-dependent T cell responses on Listeria monocytogenes infection. J Immunol 1994;153:3116-3122.
12. 12. Jones D. Foodborne listeriosis. Lancet 1990;336:1171-1174.
13. 13. Schuchat A, et al. Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. JAMA 1992;267:2041-2045.
14. 14. Jurado RL, et al. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin Infect Dis 1993;17:224-227.
15. 15. Unanue ER. Why listeriosis? A perspective on cellular immunity to infection. Immunol Rev 1997;158:5-9.
16. 16. Lane FC, Unanue ER. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med 1972;135:1104-1112.
17. 17. North RJ. The importance of thymus-derived lymphocytes in cell mediated immunity to infection. Cell Immunol 1973;1:166-177.
18. + T cells. Infect Immun 1985;48:263-266.
19. 19. Berche P, Decreusefond C, Theodorou I, Stiffel C. Impact of genetically regulated T cell proliferation on acquired resistance to Listeria monocytogenes. J Immunol 1989;132:932-939.
20. + cells, and the effect of administration of recombinant murine interferon-γ in listerial infection. J Exp Med 1990;171:1141-1154.
21. 21. Roberts AD, Ordway DJ, Orme IM. Listeria monocytogenes infection in β2 microglobulin-deficient mice. Infect Immun 1993;61:1113-1116.
22. 22. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988;167:1459-1471.
23. 23. Gaillard JL, Berche P, Sansonetti P. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect Immun 1986;52:50-55.
24. + T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol 1990;145:3540-3546.
25. 25. Berche P, Gaillard JL, Geoffroy C, Alouf JE. T cell recognition of listeriolysin O is induced during infection with Listeria monocytogenes. J Immunol 1987;139:3813-3821.
26. 26. Berche P, Gaillard J-L, Sansonetti PJ. Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J Immunol 1987;138:2266-2271.
27. 27. Neefjes JJ, Momburg F. Cell biology of antigen presentation. Curr Opin Immunol 1993;5:27-34.
28. 28. Bouwer HGA, Nelson CS, Gibbins BL, Portnoy DA, Hinrichs DJ. Listeriolysin O is a target of the immune response to Listeria monocytogenes. J Exp Med 1992;175:1467-1471.
29. 29. Bouwer HGA, Hinrichs DJ. Cytotoxic-T-lymphocyte responses to epitopes of listeriolysin O and p60 following infection with Listeria monocytogenes. Infect Immun 1996;64:2515-2522.
30. 30. Harty JT, Pamer EG. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J Immunol 1995;154:4642-4650.
31. 31. Shawar SM, Vyas JM, Rodgers JR, Rich RR. Antigen presentation by major histocompatibility complex class I-b molecules. Annu Rev Immunol 1994;12:839-880.
32. 32. Stroynowski I, Forman J. Novel molecules related to MHC antigens. Curr Opin Immunol 1995;7:97-102.
33. 33. Kurlander RJ, Shawar SM, Brown ML, Rich RR. Specialized role for a murine class I-b MHC molecule in prokaryotic host defenses. Science 1992;257:678-679.
34. 34. Pamer EG, Wang CR, Flaherty L, Fischer Lindahl K, Bevan MJ. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell 1992;70:215-223.
35. 35. Lenz LL, Dere B, Bevan MJ. Identification of an H2-M3-restricted Listeria epitope: implication for antigen presentation by M3. Immunity 1996;5:63-72.
36. 36. Princiotta MF, Lenz LL, Bevan MJ, Staerz UD. H2-M3 restricted presentation of Listeria-derived leader peptide. J Exp Med 1998;187:1711-1719.
37. + cytotoxic T cells. J Immunol 1994;152:5352-5360.
38. b as a key restricting element for Listeria-specific CTLs. J Immunol 1997;159:2795-2801.
39. 39. Bouwer HGA, et al. Listeria monocytogenes-infected hepatocytes are targets of major histocompatiblity complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun 1998;66:2814-2817.
40. 40. Gregory SH, Wing EJ. IFN-γ inhibits the replication of Listeria monocytogenes in hepatocytes. J Immunol 1993;151:1401-1409.
41. + T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α. J Immunol 1998;160:898-905.
42. 42. Portnoy DA, Schreiber RD, Connelly P, Tilney LG. γ-Interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med 1989;170:2141-2146.
43. 43. Rogers HW, Callery MP, Deck B, Unanue ER. Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol 1996;156:679-684.
44. 44. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN-γ. Immunity 1995;3:109-117.
45. 45. Huang S, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1742-1744.
46. 46. Harty JT, Schreiber RD, Bevan MJ. CD8 T cells can protect against an intracellular bacterium in an interferon γ-independent fashion. Proc Natl Acad Sci USA 1992;89:11612-11616.
47. 47. Pfeffer K, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-467.
48. 48. Rothe J, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798-802.
49. 49. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994;153:1778-1788.
50. 50. Shinagawa T, et al. Apoptosis in cultured rat hepatocytes: the effects of tumor necrosis factor α and interferon γ. J Pathol 1991;165:247-253.
51. 51. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-1316.
52. 52. Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995;109:166-176.
53. -/- mice. Role for IFN-γ in activating apoptosis of hepatocytes. J Immunol 1997;159:1418-1428.
54. 54. Tsuji H, et al. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect Immun 1997;65:1892-1898.
55. + cytolytic T lymphocytes from mice infected with the intracellular bacterium Listeria monocytogenes. J Immunol 1986;137:2688-2694.
56. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994;24:3068-3072.
57. + T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism. J Immunol 1997;158:287-293.
58. 58. Jensen ER, Glass AA, Clark WR, Wing EJ, Miller JF, Gregory SH. Fas (CD95) dependent cell mediated immunity to Listeria monocytogenes. Infect Immun 1998;66:4143-4150.
59. 59. Kagi D, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530.
60. 60. Liu C-C, Walsh CM, Young JDE. Perforin: structure and function. Immunol Today 1995;16:194-201.
61. 61. Lichtenheld MG. et al. Structure and function of human perforin. Nature 1988;355:448-451.
62. 62. Smyth MJ, O'Connor MD, Trapani JA. Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies. J Leukoc Biol 1996;60:555-562.
63. 63. Nakajiima H, Henkart PA. Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J Immunol 1994;152:1057-1063.
64. 64. Hayes MP, Berrebi GA, Henkart PA. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 1989;170:933-946.
65. 65. Shi L, Kam C-M, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992;176:1521-1529.
66. 66. Duke RC, Persechini PM, Chang S, Liu C-C, Cohen JJ, Young JDE. Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med 1989;170:1451-1456.
67. 67. Yonehara S, Ishii AI, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-1756.
68. 68. Oehm A, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis/nerve growth factor receptor superfamily: a sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-10715.
69. 69. Watanabe-Fukunaga R, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
70. 70. Ogasawara J, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
71. 71. Suda T, Nagata S. Purification and characterization of the Fas ligand that induces apoptosis. J Exp Med 1994;179:873-879.
72. 72. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
73. 73. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev 1995;146:95-115.
74. 74. Gullo CA, Esser MT, Fuller CL, Lam B. V. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones. J Immunol 1999;162:6466-6472.
75. 75. Wing EJ, Waheed A, Shadduck RK. Changes in serum colony stimulating factor (CSF) and monocytic progenitor cells during Listeria monocytogenes infection in mice. Infect Immun 1984;45:180-184.
76. 76. Itoh N, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas mediates apoptosis. Cell 1991;66:233-243.
77. + T lymphocyte clones. J Immunol 1997;158:5612-5618.
78. 78. Glass A, Walsh CM, Lynch DH, Clark WR. Regulation of the Fas lytic pathway in cloned CTL. J Immunol 1996;156:3638-3644.
79. 2+ in Fas ligand-induced lysis. J Immunol 1997;159:3140-3147.
80. 80. Zhou YW, et al. Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin-2-activated T cells. Immunol Invest 1998;27:309-322
81. 81. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-574.
82. 82. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
83. 83. Russell JH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995;7:382-388.
84. 84. Fuse Y, Nishimura H, Maeda K, Yoshikai Y. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis. Infect Immun 1997;65:1883-1891.
85. 85. Zychlinsky A, Zheng LM, Liu C-C, Young JD. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 1991;146:393-400.
86. 86. Blom WM, De Bont HJ, Meijerman I, Kuppen PJ, Mulder GJ, Nagelkerke JF. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology 1999;29:785-792.
87. 87. Alnemri ES, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
88. 88. Henkart PA. ICE family proteases: mediators of all apoptotic cell death? Immunity 1996;4:195-201.
89. 89. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16
90. 90. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306.
91. 91. Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA 1996;93:9833-9838.
92. 92. Hilbi H, Chen Y, Thirumalai K, Zychlinsky A. The interleukin 1β-converting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages. Infect Immun 1997;65:5165-5170.
93. 93. Bermudez LE, Parker A, Petrofsky M. Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases. Clin Exp Immunol 1999;116:94-99.
94. 2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect Immun 1996;64:452-459.
95. 95. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998;160:5448-5454.
96. 96. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995;375:78-81.
97. 97. Los M, et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995;375:81-83.
98. 98. Tewari M, Telford WG, Miller RA, Dixit VM. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem 1995;270:22705-22708.
99. 99. Duan H, et al. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 1996;271:16720-16724.
100. 100. Fernandes-Alnemri T, et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996;93:7464-7469.
101. 101. Stennicke HR, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084-27090.
102. 102. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-448.
103. 103. Quan LT, et al. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci USA 1996;93:1972-1976.
104. 104. Greidinger EL, Miller DK, Yamin TT, Casciola-Rosen L, Rosen A. Sequential activation of three distinct ICE-ike activities in Fas-ligated Jurkat cells. FEBS Lett 1996;390:299-303.
105. 105. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-347.
106. 106. Rosen A, Casciola-Rosen L. Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 1997;64:50-54.
107. 107. Casciola-Rosen L, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996;183:1957-1964.
108. 108. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-1634.
109. 109. Zhou BB, Li H, Yuan J, Kirschner MW. Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc Natl Acad Sci USA 1998;95:6785-6790.
110. 110. Tewari M, et al. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-809.
111. 111. Miura M, Friedlander RM, Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 1995;92:8318-8322.
112. 112. Kunstle G, et al. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α. Immunol Lett 1997;55:5-10.
113. 113. Rouquet N, Pages JC, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol 1996;6:1192-1195.
114. 114. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998;160:3480-3486.
115. 115. Cursio R, Gugenheim J, Ricci JE, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999;13:253-261.
116. 1-induced apoptosis in rat heptocytes. Hepatology 1997;25:1516-1526.
117. 117. Jones RA, et al. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology 1998;27:1632-1642.
118. 118. Jones RA, Johnson VL, Hinton RH, Poirier GG, Chow SC, Kass GE. Liver poly(ADP-ribose)polymerase is resistant to cleavage by caspases. Biochem Biophys Res Commun 1999;256:436-441.
119. 119. Cheers C, Sandrin MS. Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol 1983;78:199-205.
120. + cells in anti-bacterial protection to facultative intracellular bacteria. J Immunol 1985;134:569-572.
121. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992;175:1531-1538.
122. 122. Lukacs K, Kurlander RJ. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells. J Immunol 1989;143:3731-3736.
123. 123. Seaman MS, Perarnau B, Lindahl KF, Lemonnier FA, Forman J. Response to Listeria monocytogenes in mice lacking MHC class Ia molecules. J Immunol 1999;162:5429-5436.
124. 124. Kerksiek KM, Busch DH, Pilip IM, Allen SE, Pamer EG. H2-M3-restricted T cells in bacterial infection. Rapid primary but diminished memory responses. J Exp Med 1999;190:195-204.
125. 125. Goossens PL, Jouin H, Milon G. Dynamics of lymphocytes and inflammatory cells recruited in liver during murine listeriosis: a cytofluorimetric study. J Immunol 1991;147:3514-3520.
126. 126. Busch DH, Pilip I, Pamer EG. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med 1998;188:61-70.
127. 127. Busch DH, Pamer E. T cell affinity maturation by selective expansion during infection. J Exp Med 1999;189:701-709.
128. 128. Busch DH, Pilip IM, Vijh S, Pamer EG. Co-ordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998;8:353-362.
129. 129. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
130. 130. Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur J Immunol 1997;27:421-430.
131. 131. Wolpert EZ, Grufman P, Sandberg JK, Tegnesjo A, Karre K. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J Immunol 1999;161:4499-4505.
132. 132. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994;264:365-367.
133. 133. Gomez GA, Jacobson LE, Arsenio JA, Nauta RJ. Pre-existing liver disease in the trauma patient. Crit Care Clin 1994;10:555-566.
134. 134. Navasa M, Rimola A, Rodes J. Bacterial infections in liver disease. Semin Liver Dis 1997;17:323-333.